Dangerous dogmas in medicine: The nonthyroidal illness syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 1, 1999, Pages 151-169

  De Groot, Leslie J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LIOTHYRONINE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ARTICLE; BASAL METABOLIC RATE; CRITICAL ILLNESS; EUTHYROID SICK SYNDROME; HORMONE ACTION; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STARVATION; SYNDROME; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ADAPTATION, PHYSIOLOGICAL; CYTOKINES; EUTHYROID SICK SYNDROMES; HUMANS; HYPOTHYROIDISM; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 0032933702     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.1.151     Document Type: Article

References (107)

1. 1. McIver B, Gorman CA. 1997 Euthyroid sick syndrome: an overview. Thyroid. 7:125-132.
2. 3 syndrome during caloric deprivation and non-thyroidal illness: an overview. Acta Med Kaust. 15:42-45.
3. 3. Chow CC, Mak TW, Chan CH, Cockram CS. 1995 Euthyroid sick syndrome in tuberculosis before and after treatment. Ann Clin Biochem. 32:385-391.
4. 4. Phillips RH, Valente WA, Caplan ES, Connor TB, Wiswell JG. 1984 Circulating thyroid hormone changes in acute trauma: prognostic implications for clinical outcome. J Trauma. 24:116-119.
5. 5. Cherem HJ, Nellen HH, Barabejski FG, Chong MBA, Lifshitz GA. 1992 Thyroid function and abdominal surgery. A longitudinal study. Arch Med Res. 23:143-147.
6. 3 syndrome following acute myocardial infarct. Klin Wochenschrift. 65:129-133.
7. 7. Eber B, Schumacher M, Langsteger W, et al. 1995 Changes in thyroid hormone parameters after acute myocardial infarction. Cardiology. 86:152-156.
8. 8. Holland FW, Brown PS, Weintraub BD, Clark RE. 1991 Cardiopulmonary bypass and thyroid function: a "euthyroid sick syndrome." Ann Thorac Surg. 52:46-50.
9. 9. Vexiau P, Perez-Castiglioni P, Socie G, et al. 1993 The 'euthyroid sick syndrome:' incidence, risk factors and prognostic value soon after allogeneic bone marrow transplantation. Br J Hematol. 85:778-782.
10. 4 to T3 conversion in the rat. Metabolism. 27:1680-1690.
11. 11. Welle SL, Campbell RG. 1986 Decrease in resting metabolic rate during rapid weight loss is reversed by low dose thyroid hormone treatment. Metabolism. 35:289-291.
12. 12. Maldonado LS, Murata GH, Hershman JM, Braunstein GD. 1992 Do thyroid function tests independently predict survival in the critically ill? Thyroid 2:119.
13. 13. Vaughan GM, Mason AD, McManus WF, Pruitt BA. 1985 Alterations of mental status and thyroid hormones after thermal injury. J Clin Endocrinol Metab. 60:1221.
14. 14. De Marinis L, Mancini A, Masala R, Torlontano M, Sandric S, Barbarino A. 1985 Evaluation of pituitary-thyroid axis response to acute myocardial infarction. J Endocrinol Invest. 8:507.
15. 15. Wartofsky L, Burman KD. 1982 Alterations in thyroid function in patients with systemic illnesses: the "euthyroid sick syndrome." Endocr Rev. 3:164-217.
16. 16. Kaptein EM. 1997 Clinical relevance of thyroid hormone alterations in nonthyroidal illness. Thyroid Int. 4:22-25.
17. 17. Docter R, Krenning EP, de Jong M, Hennemann G. 1993 The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol (Oxf). 39:499-518.
18. 18. Chopra IJ, Huang TS, Boado R, Solomon DH, Chua Teco GN. 1987 Evidence against benefit from replacement doses of thyroid hormones in nonthyroidal illness: studies using turpentine oil-injected rat. J Endocrinol Invest. 10:559-564.
19. 19. Surks MI, Hupart KH, Pan C, Shapiro LE. 1988 Normal free thyroxine in critical nonthyroidal illnesses measured by ultra filtration of undiluted serum and equilibrium dialysis. J Clin Endocrinol Mctab. 67:1031-1039.
20. 20. Melmed S, Geola FL, Reed AW, Pekary AE, Park J, Hershman JM. 1982 A comparison of methods for assessing thyroid function in nonthyroidal illness. J Clin Endocrinol Metab. 54:300-306.
21. 21. Kaptein EM, MacIntyre SS, Weiner JM, Spencer CA, Nicoloff JT. 1981 Free thyroxine estimates in nonthyroidal illness: comparison of eight methods. J Clin Endocrinol Metab. 52:1073-1077.
22. 22. Chopra IJ, Solomon DH, Hepner GW, Morgenstein AA. 1979 Misleadingly low free thyroxine index and usefulness of reverse triiodothyronine measurement in nonthyroidal illnesses. Ann Intern Med. 90:905-912.
23. 23. Bacci V, Schussler GC, Kaplan TB. 1982 The relationship between serum triiodothyronine and thyrotropin during systemic illness. J Clin Endocrinol Metab. 54:1229-1235.
24. 24. Sapin R, Schlienger JL, Kaltenbach G, et al. 1995 Determination of free triiodothyronine by six different methods in patients with nonthyroidal illness and in patients treated with amiodarone. Ann Clin Biochem. 32:314-324.
25. 3) in undiluted serum by equilibrium dialysis/radioimmunoassay. Thyroid. 6:255-259.
26. 26. Chopra IJ. 1998 Simultaneous measurement of free thyroxine and free 3,5,3′-triiodothyronine in undiluted serum by direct equilibrium dialysis/radioimmunoassay: evidence that free triiodothyronine and free thyroxine are normal in many patients with the low triiodothyronine syndrome. Thyroid. 8:249-257.
27. 27. Klemperer JD, Klein I, Gomez M, et al. 1995 Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med. 333:1522-1527.
28. 3 as measured by the pulse wave arrival time. Metabolism. 32:9-13.
29. 29. Kaptein EM. 1996 Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocr Rev. 17:45-63.
30. 30. Liewendahl K, Helenius T, Naveri H, Tikkanen H. 1992 Fatty acid-induced increase in serum dialyzable free thyroxine after physical exercise: implication for nonthyroidal illness. J Clin Endocrinol Metab. 74:1361-1365.
31. 31. Mendel CM, Frost PH, Cavalieri RR. 1986 Effect of free fatty acids on the concentration of free thyroxine in human serum: the role of albumin. J Clin Endocrinol Metab. 63:1394-1399.
32. 32. Jaume JC, Mendel CM, Frost PH, Greenspan FS, Laughton CW. 1996 Extremely low doses of heparin release lipase activity into the plasma and can thereby cause artifactual elevations in the serum-free thyroxine concentration as measured by equilibrium dialysis. Thyroid. 6:79.
33. 33. Uchimura H, Nagataki S, Tabuchi T, Mizuno M, Ingbar SH. 1976 Measurements of free thyroxine: comparison of percent of free thyroxine in diluted and undiluted sera. J Clin Endocrinol Metab. 42:561-566.
34. 4 syndrome of nonthyroidal illness. J Clin Endocrinol Metab. 61:239-246.
35. 35. Wang Y-S, Hershman JM, Pekary AE. 1985 Improved ultarfiltration method for simultaneous measurement of free thyroxine and free triiodothyronine in serum. Clin Chem. 31:517-522.
36. 36. Chopra IJ, Huang T-S, Beredo A, Solomon DH, Chua Teco GN, Mead JF. 1985 Evidence for an inhibitor of extrathyroidal conversion of thyroxine to 3,5,3′-triiodothyronine in sera of patients with nonthyroidal illnesses. J Clin Endocrinol Metab. 60:666.
37. 37. Mendel CM, Laughton CW, McMahon FA, Cavalieri RR. 1991 Inability to detect an inhibitor of thyroxine-serum protein binding in sera from patients with nonthyroidal illness. Metabolism. 40:491-502.
38. 38. Csako G, Zweig MH, Benson C, Ruddel M. 1987 On the albumin-dependence of the measurement of free thyroxine. II. Patients with nonthyroidal illness. Clin Chem. 33:87-92.
39. 39. Chopra IJ, Chua Teco GN, Mead JF, et al. 1985 Relationship between serum free fatty acids and thyroid hormone binding inhibitor in nonthyroid illnesses. J Clin Endocrinol Metab. 60:980-984.
40. 40. Brent GA, Hershman JM. 1986 Thyroxine therapy in patients with severe nonthyroidal illnesses and lower serum thyroxine concentration. J Clin Endocrinol Metab. 63:1-8.
41. 41. Chopra IJ. 1996 Nonthyroidal illness syndrome or euthyroid sick syndrome? Endocr Prac. 2:45-52.
42. 42. Franklyn JA, Black EG, Betteridge J, Sheppard MC. 1994 Comparison of second and third generation methods for measurement of serum thyrotropin in patients with overt hyperthyroidism, patients receiving thyroxine therapy, and those with nonthyroidal illness. J Clin Endocrinol Metab. 78:1368-1371.
43. 4-syndrome.' Acta Endocrinol (Coepnh). 101:542-549.
44. 44. Faber J, Kirkegaard C, Rasmussen B, Westh H, Busch-Sorensen M, Jensen IW. 1987 Pituitary-thyroid axis in critical illness. J Clin Endocrinol Metab. 65:315-320.
45. 45. Arem R, Deppe S. 1990 Fatal nonthyroidal illness may impair nocturnal thyrotropin levels. Am J Med. 88:258-262.
46. 46. Lee H-Y, Suhl J, Pekary AE, Hershman JM. 1987 Secretion of thyrotropin with reduced concanavalin-A-binding activity in patients with severe nonthyroid illness. J Clin Endocrinol Metab. 65:942.
47. 47. Spratt DI, Bigos ST, Beitins I, Cox F, Longcope C, Orav J. 1992 Both hyperand hypogonadotropic hypogonadism occur transiently in acute illness: bio- and immunoactive gonadorropins. J Clin Endocrinol Metab. 75:1562-1570.
48. 48. Spratt DI, Cox F, Orav J, Moloney J, Bigos T. 1993 Reproductive axis suppression in acute illness is related to disease severity. J Clin Endocrinol Metab. 76:1548-1554.
49. 49. Kaptein EM, Grieb DA, Spencer CA, Wheeler WS, Nicoloff JT. 1981 Thyroxine metabolism in the low thyroxine state of critical nonthyroidal illnesses. J Clin Endocrinol Metab. 53:764-771.
50. 50. Kaptein EM, Robinson WJ, Grieb DA, Nicoloff JT. 1982 Peripheral serum thyroxine, triiodothyronine and reverse triiodothyronine kinetics in the low thyroxine state of acute nonthyroidal illnesses. A noncompartmental analysis. J Clin Invest. 69:526-535.
51. 51. Lim VS, Fang VS, Katz AI, Refetoff S. 1977 Thyroid dysfunction in chronic renal failure. A study of the pituitary-thyroid axis and peripheral turnover kinetics of thyroxine and triiodo-thyronine. J Clin Invest. 60:522-534.
52. 52. Lim C-F, Docter R, Visser TJ, et al. 1993 Inhibition of thyroxine transport into cultured rat hepatocytes by serum of nonuremic critically ill patients: effects of bilirubin and nonesterified fatty acids. J Clin Endocrinol Metab. 76:1165-1172.
53. 53. Vos RA, de Jong M, Bernard BF, Docter R, Krenning EP, Hennemann G. 1995 Impaired thyroxine and 3,5,3′-triiodothyronine handling by rat hepatocytes in the presence of serum of patients with nonthyroidal illness. J Clin Endocrinol Metab. 80:2364-2370.
54. 54. Lim C-F, Docter R, Krenning EP, van Toor H, Bernard B, de Jong M, Hennemann G. 1994 Transport of thyroxine into cultured hepatocytes: effects of mild nonthyroidal illness and calorie restriction in obese subjects. Clin Endocrinol (Oxf). 40:79-85.
55. 55. Sarne DH, Refetoff S. 1985 Measurement of thyroxine uptake from serum by cultured human hepatocytes as an index of thyroid status: reduced thyroxine uptake from serum of patients with nonthyroidal illness. J Clin Endocrinol Metab. 61:1046-1052.
56. 56. Arem R, Wiener GJ, Kaplan SG, Kim H-S, Reichlin S, Kaplan MM. 1993 Reduced tissue thyroid hormone levels in fatal illness. Metabolism. 42:1102-1108.
57. 57. DeGroot LJ, Manowitz N, Chait L, Mayor G. Differential end organ responsiveness to suboptimal thyroid hormone concentrations as assessed by short-term withdrawal of levothyroxine sodium in athyreotic patients [Abstract]. Proc of the 70th Annual Meet of the Am Thyroid Assoc. 1997.
58. 58. Brent GA, Hershman JM, Reed AW, Sastre A, Lieberman J. 1986 Serum angiotensin converting enzyme in severe nonthyroidal illness associated with low serum thyroxine concentration. Ann Intern Med. 100:680-683.
59. 59. Seppel T, Becker A, Lippert F, Schlaghecke R. 1996 Serum sex hormone-binding globulin and osteocalcin in systemic nonthyroidal illness associated with low thyroid hormone concentrations. J Clin Endocrinol Metab. 81:1663-1665.
60. 60. Kaplan MM. 1979 Subcellular alterations causing reduced hepatic thyroxine-5′-monodeiodinase activity in fasted rats. Endocrinology. 104:58-64.
61. 3 syndrome after major trauma. Intens Care Med. 22:575-581.
62. 62. Blake NG, Eckland JA, Foster OJF, Lightman SL. 1991 Inhibition of hypothalamic thyrotropin-releasing hormone messenger ribonucleic acid during food deprivation. Endocrinology. 129:2714-2718.
63. 63. Fliers E, Guldenaar SEF, Wiersinga WM, Swaab DF. 1997 Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. J Clin Endocrinol Metab. 82:4032-4036.
64. 64. Van den Berghe G, De Zegher F, Baxter RC, et al. 1998 Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. J Clin Endocrinol Metab. 83:309-319.
65. 65. Nicoloff JT, Fisher DA, Appleman Jr MD. 1970 The role of glucocorticoids in the regulation of thyroid function in man. J Clin Invest. 49:1922.
66. 66. Brabant G, Brabant A, Ranft U. 1987 Circadian and pulsatile thyrotropin secretion in euthyroid man under the influence of thyroid hormone and glucocorticoid administration. J Clin Endocrinol Metab. 65:83.
67. 67. Benker G, Raida M, Olbricht T, Wagner R, Reinhardt W, Reinwein D. 1990 TSH secretion in Cushing's syndrome: relation to glucocorticoid excess, diabetes, goiter, and the 'sick euthyroid syndrome.' Clin Endocrinol (Oxf). 33:777-786.
68. 68. Bianco AC, Nunes MT, Hell NS, Maciel RMB. 1987 The role of glucocorticoids in the stress-induced reduction of extrathyroidal 3,5,3′-triiodothyronine generation in rats. Endocrinology. 120:1033-1038.
69. 69. Lim VS, Passo C, Murata Y, Ferrari E, Nakamura H, Refetoff S. 1984 Reduced triiodothyronine content in liver but not pituitary of the uremic rat model: demonstration of changes compatible with thyroid hormone deficiency in liver only. Endocrinology. 114:280-286.
70. 3AC): is it an intracellular autocrine acting form of thyroid hormone [Abstract OR1-1]? Proc of the 79th Annual Meet of The Endocrine Soc. 1997.
71. 71. Hermus ARMM, Sweep CGJ, van der Meer MJM, et al. 1992 Continuous infusion of interleukin-1β induces a nonthyroidal illness syndrome in the rat. Endocrinology. 131:2139-2146.
72. 72. Sato K, Satoh T, Shizume K, et al. 1990 Inhibition of 125-I organification and thyroid hormone release by interleukin-1, tumor necrosis factor-α, and interferon-γ in human thyrocytes in suspension culture. J Clin Endocrinol Metab. 70:1735-1743.
73. 73. Cannon JG, Tompkins RG, Gelfand JA, et al. 1990 Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis. 161:79-84.
74. 74. van der Poll T, Van Zee KJ, Endert E, et al. 1995 Interleukin-1 receptor blockade does not affect endotoxin-induced changes in plasma thyroid hormone and thyrotropin concentrations in man. J Clin Endocrinol Metab. 80:1341-1346.
75. 75. van der Poll T, Romijn JA, Wiersinga WM, Saurwein HP. 1990 Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab. 71:1567-1572.
76. 76. Chopra IJ, Sakane S, Chua Teco GN. 1991 A study of the serum concentration of tumor necrosis factor-α in thyroidal and nonthyroidal illnesses. J Clin Endocrinol Metab. 72:1113-1116.
77. 77. Bartalena L, Brogioni S, Grasso L, Velluzzi F, Martino E. 1994 Relationship of the increased serum interleukin-6 concentration to changes of thyroid function in nonthyroidal illness. J Endocrinol Invest. 17:269-274.
78. 78. Boelen A, Platvoet-ter Schiphorst MC, Wiersinga WM. 1993 Association between serum interleukin-6 and serum 3,5,3′-triiodothyronine in nonthyroidal illness. J Clin Endocrinol Metab. 77:1695-1699.
79. 79. Stouthard JML, van der Poll T, Endert E, et al. 1994 Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans. J Clin Endocrinol Metab. 79:1342-1346.
80. 80. Boelen A, Platvoet-ter Schiphorst MC, Wiersinga WM. 1997 Immunoneutralization of interleukin-1, tumor necrosis factor, interleukin-6 or interferon does not prevent the LPS-induced sick euthyroid syndrome in mice. J Endocrinol. 153:115-122.
81. 81. Boelen A, Platvoet-ter Schiphorst MC, Wiersinga WM. 1996 Relationship between serum 3,5,3′-triiodothyronine and serum interleukin-8, interleukin-10 or interferon-γ in patients with nonthyroidal illness. J Endocrinol Invest. 19:480-483.
82. 82. Boelen A, Platvoet-ter Schiphorst MC, Wiersinga WM. 1995 Soluble cytokine receptors and the low 3,5,3′-triiodothyronine syndrome in patients with nonthyroidal disease. J Clin Endocrinol Metab. 80:971-976.
83. 83. Custro N, Scafidi V, Costanzo G, Calanni S. 1989 Role of high blood glucagon in the reduction of serum levels of triiodothyronine in severe nonthyroid diseases. Minerva Endocrinol. 14:221-226.
84. 84. Van den Berghe G, de Zegher F, Lauwers P. 1994 Dopamine and the sick euthyroid syndrome in critical illness. Clin Endocrinol (Oxf). 41:731-737.
85. 85. Walfish PG, Orrego H, Israel Y, Blake J, Kalant H. 1979 Serum triiodothyronine and other clinical and laboratory indices of alcoholic liver disease Ann Intern Med. 91:13-16.
86. 86. Liewendahl K, Helenius T, Tanner P, Salaspuro M. 1983 Serum free thyroid hormone concentrations and indices in alcoholic liver cirrhosis, primary biliary cirrhosis and chronic active hepatitis. Acta Endocrinol (Copenh). 251:21-26.
87. 87. Chopra IJ, Solomon DH, Chopra U, Young RT, Chua Teco GN. 1974 Alterations in circulating thyroid hormones and thyrotropin in hepatic cirrhosis: evidence for euthyroidism despite subnormal serum triiodothyronine. J Clin Endocrinol Metab. 39:501-511.
88. 88. Kaptein EM, Levitan D, Feinstein EI, Nicoloff JT, Massry SG. 1981 Alterations of thyroid hormone indices in acute renal failure and in acute critical illness with and without acute renal failure. Am J Nephrol. 1:138-143.
89. 89. Ramirez G, Jubiz W, Gutch CF, Bloomer HA, Siegler R, Kolff WJ. 1973 Thyroid abnormalities in renal failure. A study of 53 patients on chronic hemodialysis. Ann Intern Med. 79:500-504.
90. 90. Lim VS, Henriquez C, Seo H, Refetoff S, Martino E. 1980 Thyroid function in a uremic rat model. Evidence suggesting tissue hypothyroidism. J Clin Invest. 66:946-954.
91. 91. Lim VS, Tsalikian E, Flanigan MJ. 1989 Augmentation of protein degradation by L-triiodothyronine in uremia. Metabolism. 38:1210-1215.
92. 92. Welle S, O'Connell M, Danforth E, Campbell R. 1984 Decreased free fraction of serum thyroid hormones during carbohydrate overfeeding. Metabolism. 33:837.
93. 93. Welle SL, Campbell RG. 1986 Decrease in resting metabolic rate during rapid weight loss is reversed by low dose thyroid hormone treatment. Metabolism. 35:289-291.
94. 94. DeGroot LJ, Coleoni AH, Rue PA, Seo H, Martino E, Refetoff S. 1977 Reduced nuclear triiodothyronine receptors in starvation-induced hypothyroidism. Biochem Biophys Res Commun. 79:173-178.
95. 95. Sanchez B, Jolin T. 1991 Triiodothyronine-receptor complex in rat brain: effects of thyroidectomy, fasting, food restriction, and diabetes. Endocrinology. 129:361-367.
96. 3 as measured by the pulse wave arrival time. Metabolism. 32:9-13.
97. 97. Gardner DF, Kaplan MM, Stanley CA, Utiger RD. 1979 Effect of triiodothyronine replacement on the metabolic and pituitary responses to starvation. N Engl J Med. 300:579-584.
98. 3 and reverse T3 administration on muscle protein catabolism during fasting as measured by 3-methyl-histidine excretion. Metabolism. 28:805-813.
99. 99. Byerley LO, Heber D. 1996 Metabolic effects of triodothyronine replacement during fasting in obese subjects. J Clin Endocrinol Metab. 81:968-976.
100. 100. Becker RA, Vaughan GM, Ziegler MG, et al. 1982 Hypermetabolic low triiodothyronine syndrome of burn injury. Crit Care Med. 10:870-875.
101. 101. Little JS. 1985 Effect of thyroid hormone supplementation on survival after bacterial infection. Endocrinology. 117:1431-1435.
102. 102. Chopra IJ, Huang TS, Boado R, Solomon DH, Chua Teco GN. 1987 Evidence against benefit from replacement doses of thyroid hormones in nonthyroidal illness: studies using turpentine oil-injected rat. J Endocrinol Invest. 10:559.
103. 103. Hsu R-B, Huang T-S, Chen Y-S, Chu S-H. 1995 Effect of triiodothyronine administration in experimental myocardial injury. J Endocrinol Invest. 18:702-709.
104. 104. Schoenberger W, Grimm W, Emmrich P, Gempp W. 1979 Thyroid administration lowers mortality in premature infants. Lancet. 2:1181.
105. 105. Shigematsu H, Shatney CH. 1988 The effect of triiodothyronine and reverse triiodothyronine on canine hemorrhagic shock. Nippon Geka Gakkai Zasshi. 89:1587-1593.
106. 106. Facktor MA, Mayor GH, Nachreiner RF, D'Alecy LG. 1993 Thyroid hormone loss and replacement during resuscitation from cardiac arrest in dogs. Resuscitation. 26:141-162.
107. 107. Hamilton MA, Stevenson LW. 1996 Thyroid hormone abnormalities in heart failure: possibilities for therapy. Thyroid. 6:527-529.